Author:
Li Xinjuan,Li Yuting,Liu Zhengwei,Zhang Qiyao,Zhou Yi,Yu Lintao,Liu Wenmin,Sang Zhipei
Funder
the Science and Technology Project of Henan Province
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Hodson R. Alzheimer’s disease. Nature. 2018;559:S1. https://doi.org/10.1038/d41586-018-05717-6
2. Simon L, Chloé B, Wendy W. World Alzheimer Report 2023: Reducing dementia risk: never too early, never too late. London, England: Alzheimer’s Disease International; 2023. https://www.alzint.org/u/World-Alzheimer-Report-2023
3. Sang Z, Wang K, Dong J, Tang L. Alzheimer’s disease: Updated multi-targets therapeutics are in clinical and in progress. Eur J Med Chem. 2022;238:114464. https://doi.org/10.1016/j.ejmech.2022.114464
4. Tatulian SA. Challenges and hopes for Alzheimer’s disease. Drug Discov Today. 2022;27:1027–43. https://doi.org/10.1016/j.drudis.2022.01.016
5. Kumar B, Thakur A, Dwivedi AR, Kumar R, Kumar V. Multi-target-directed ligands as an effective strategy for the treatment of Alzheimer’s disease. Curr Med Chem. 2022;29:1757–803. https://doi.org/10.2174/0929867328666210512005508